176 related articles for article (PubMed ID: 27398153)
21. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
Zhuo Z; Yu H
Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
[TBL] [Abstract][Full Text] [Related]
22. Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal.
Kiho T; Kato M; Usui S; Hirano K
Clin Chim Acta; 2005 Aug; 358(1-2):139-45. PubMed ID: 15946656
[TBL] [Abstract][Full Text] [Related]
23. Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1.
Xue J; Li L; Li N; Li F; Qin X; Li T; Liu M
Eur J Pharmacol; 2019 Sep; 859():172541. PubMed ID: 31319067
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of endometrial carcinoma by Kaempferol is interceded through apoptosis induction, G2/M phase cell cycle arrest, suppression of cell invasion and upregulation of m-TOR/PI3K signalling pathway.
Lei X; Guo J; Wang Y; Cui J; Feng B; Su Y; Zhao H; Yang W; Hu Y
J BUON; 2019; 24(4):1555-1561. PubMed ID: 31646808
[TBL] [Abstract][Full Text] [Related]
25. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
26. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of
Rho SB; Byun HJ; Kim BR; Lee CH
Biomol Ther (Seoul); 2021 Nov; 29(6):650-657. PubMed ID: 34607979
[TBL] [Abstract][Full Text] [Related]
28. Protopanaxadiol and metformin synergistically inhibit estrogen-mediated proliferation and anti-autophagy effects in endometrial cancer cells.
Gu CJ; Cheng J; Zhang B; Yang SL; Xie F; Sun JS; Huang LQ; Yu JJ; Li MQ
Am J Transl Res; 2017; 9(9):4071-4082. PubMed ID: 28979682
[TBL] [Abstract][Full Text] [Related]
29. Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer.
Deng B; Kong W; Suo H; Shen X; Newton MA; Burkett WC; Zhao Z; John C; Sun W; Zhang X; Fan Y; Hao T; Zhou C; Bae-Jump VL
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001668
[TBL] [Abstract][Full Text] [Related]
30. The enhancement of oxidative DNA damage by anti-diabetic metformin, buformin, and phenformin, via nitrogen-centered radicals.
Ohnishi S; Mizutani H; Kawanishi S
Free Radic Res; 2016 Aug; 50(8):929-37. PubMed ID: 27328723
[TBL] [Abstract][Full Text] [Related]
31. Medroxyprogesterone Reverses Tolerable Dose Metformin-Induced Inhibition of Invasion via Matrix Metallopeptidase-9 and Transforming Growth Factor-β1 in KLE Endometrial Cancer Cells.
Suh DH; Lee S; Park HS; Park NH
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33172126
[TBL] [Abstract][Full Text] [Related]
32. Growth inhibition of Saos-2 osteosarcoma cells by lactucopicrin is mediated via inhibition of cell migration and invasion, sub-G1 cell cycle disruption, apoptosis induction and Raf signalling pathway.
Meng Q; Tang B; Qiu B
J BUON; 2019; 24(5):2136-2140. PubMed ID: 31786886
[TBL] [Abstract][Full Text] [Related]
33. Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression.
Zhang Z; Dong L; Sui L; Yang Y; Liu X; Yu Y; Zhu Y; Feng Y
Int J Gynecol Cancer; 2011 Feb; 21(2):213-21. PubMed ID: 21270604
[TBL] [Abstract][Full Text] [Related]
34. NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo.
Zhang L; Han J; Jackson AL; Clark LN; Kilgore J; Guo H; Livingston N; Batchelor K; Yin Y; Gilliam TP; Gehrig PA; Sheng X; Zhou C; Bae-Jump VL
J Hematol Oncol; 2016 Sep; 9(1):91. PubMed ID: 27655410
[TBL] [Abstract][Full Text] [Related]
35. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
[TBL] [Abstract][Full Text] [Related]
36. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.
Stine JE; Guo H; Sheng X; Han X; Schointuch MN; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Jan; 7(1):946-60. PubMed ID: 26503475
[TBL] [Abstract][Full Text] [Related]
37. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
Niu YJ; Shi HR; Xie Y
Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):135-40. PubMed ID: 26917483
[TBL] [Abstract][Full Text] [Related]
38. Metformin May Alter the Metabolic Reprogramming in Cancer Cells by Disrupting the L-Arginine Metabolism: A Preliminary Computational Study.
Espinosa-Rodriguez BA; Treviño-Almaguer D; Carranza-Rosales P; Ramirez-Cabrera MA; Ramirez-Estrada K; Arredondo-Espinoza EU; Mendez-Lopez LF; Balderas-Renteria I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982390
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer Cells.
Kong W; Lv N; Wysham WZ; Roque DR; Zhang T; Jiao S; Song D; Chen J; Bae-Jump VL; Zhou C
J Cancer; 2015; 6(12):1337-45. PubMed ID: 26640594
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
Bae-Jump VL; Zhou C; Boggess JF; Gehrig PA
Cancer; 2009 Sep; 115(17):3887-96. PubMed ID: 19484784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
